<DOC>
	<DOCNO>NCT01632150</DOCNO>
	<brief_summary>The purpose study determine safety tolerability elotuzumab administer combination thalidomide dexamethasone treatment relapse and/or refractory multiple myeloma .</brief_summary>
	<brief_title>Safety Study Elotuzumab Combination With Thalidomide Dexamethasone Relapsed and/or Refractory Multiple Myeloma</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com . Key Confirmed diagnosis previously treat multiple myeloma progression document criterion International Myeloma Working Group recent therapy Patient receive 5 few prior line therapy Eastern Cooperative Oncology Group performance status 0 1 ( safety leadin cohort ) 0 2 ( additional patient ) Measurable disease define least 1 follow : Serum immunoglobulin ( Ig ) G , IgA , IgM , monoclonal ( M ) protein level ≥0.5 g/dL serum IgD M protein level ≥0.05 g/dL ; Urine M protein level ≥200 mg excrete 24hour collection sample ; Involved serum free light chain level ≥10 mg/dL , provide free light chain ratio abnormal Key Solitary bone solitary extramedullary plasmacytoma evidence plasma cell dyscrasia Monoclonal gammopathy undetermined significance , smolder myeloma , Waldenström 's macroglobulinemia Left ventricular ejection fraction echocardiogram Multi Gated Acquisition ≤50 % Electrocardiogram finding QTc ≥450 msec Active plasma cell leukemia ( define either 20 % peripheral white blood cell , compose plasma/CD138+ cell absolute plasma cell count 2*10^9/L ) Diagnosis nonsecretory myeloma Active hepatitis A , B , C virus infection Grade ≥2 neuropathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>